XML 24 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATIONS (Details)
3 Months Ended 6 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Jun. 30, 2014
USD ($)
Jun. 30, 2013
USD ($)
Jun. 30, 2014
USD ($)
Jun. 30, 2013
USD ($)
Dec. 31, 2013
USD ($)
Jun. 30, 2014
Convertible promissory notes
USD ($)
Nov. 06, 2013
Convertible promissory notes
USD ($)
Jun. 30, 2014
ProteoSys
USD ($)
Jun. 30, 2014
ProteoSys
EUR (€)
Feb. 11, 2014
Mind-NRG
USD ($)
Feb. 11, 2014
Mind-NRG
USD ($)
Feb. 11, 2014
Mind-NRG
ProteoSys
USD ($)
Feb. 11, 2014
Mind-NRG
In-process research and development
USD ($)
Nov. 12, 2013
Sonkei
USD ($)
Nov. 12, 2013
Sonkei
USD ($)
Jun. 30, 2014
Sonkei
Convertible promissory notes
USD ($)
Jun. 30, 2014
Sonkei
Convertible promissory notes
EUR (€)
Nov. 12, 2013
Sonkei
Convertible promissory notes
USD ($)
Nov. 12, 2013
Sonkei
Convertible promissory notes
EUR (€)
Nov. 12, 2013
Sonkei
Non-employee holding common stock with nonrecourse note
Nov. 12, 2013
Sonkei
Non-employee holding common stock with nonrecourse note
Nov. 12, 2013
Sonkei
In-process research and development
USD ($)
BUSINESS COMBINATIONS                                            
Conversion ratio                           0.383                
Number of shares of common stock                   1,481,583       2,423,368                
Number of shares held in escrow                   148,160                        
Issuance of shares for business acquisition (in shares)                           1,997,192                
Estimated fair value (in dollars per share)                     $ 11.17       $ 9.49              
Aggregate consideration                   $ 16,500,000       $ 18,900,000                
Voting interest (as a percent)                     100.00%                      
Number of shares held                                         1,112,500  
Number of shares issued                                       426,176    
Net operating losses                             5,300,000              
Assets acquired and liabilities assumed based on estimated fair values                                            
Cash                     1,167,869       631,478              
Other Assets                     71,130                      
Goodwill 15,104,239   15,104,239   7,918,387           7,185,852       7,918,387              
Intangible assets                         15,200,000                 19,000,000
Deferred tax liability                     (6,080,000)       (7,588,600)              
Accrued expenses                     (321,417)       (334,423)              
Derivative liability                             (3,476)              
Milestone payable               (682,250) (500,000)     (681,600)                    
Convertible promissory notes (see Note 7)           (1,300,000) (1,300,000)                 (700,000) (518,519) (680,000) (518,519)      
Total                     16,541,834       18,943,366              
Unaudited pro forma financial information                                            
Operating loss $ (19,365,662) $ (928,569) $ (22,756,955) $ (1,571,977)                                    
Loss per share (in dollars per share) $ (2.55) $ (0.13) $ (2.99) $ (0.22)